L. de Bolle

发表

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.

M. Otto, E. De Clercq, L. Naesens, 2004, Biochemical pharmacology.

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G2 phase of the cell cycle

E. De Clercq, L. Naesens, E. Verbeken, 2004 .

Antiviral agents active against human herpesviruses HHV‐6, HHV‐7 and HHV‐8

E. De Clercq, L. Naesens, J. Neyts, 2001, Reviews in Medical Virology.

Quantitative analysis of human herpesvirus 6 cell tropism

Wiley Interscience, E. De Clercq, L. Naesens, 2005, Journal of medical virology.

Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.

E. De Clercq, L. Naesens, J. Neyts, 2001, Antiviral research.

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.

C. Manichanh, E. De Clercq, L. Naesens, 2004, Antiviral research.

ACYCLIC/CARBOCYCLIC GUANOSINE ANALOGUES AS ANTI-HERPESVIRUS AGENTS

P Leyssen, E. De Clercq, L. Naesens, 2001 .

Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir.

C. Manichanh, E. De Clercq, L. Naesens, 2002, Molecular pharmacology.

Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy

E. De Clercq, L. Naesens, L. de Bolle, 2005, Clinical Microbiology Reviews.

Productive Infection of Primary Macrophages with Human Herpesvirus 7

E. De Clercq, D. Schols, S. Aquaro, 2001, Journal of Virology.

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses.

E. De Clercq, L. Naesens, A. Loregian, 2006, Antiviral research.

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle.

E. De Clercq, L. Naesens, E. Verbeken, 2004, FEBS letters.